Remove Informed Consent Remove Medicare Remove Presentation Remove US Department of Health and Human Services
article thumbnail

OIG Advisory Opinion Alert: Yet Another Favorable Decision for Medical Device Manufacturers

Healthcare Law Blog

On Thursday, March 16, the Office of the Inspector General for the Department of Health and Human Services (“OIG”) issued OIG Advisory Opinion (“AO”) No. 22-05 , relating to subsidization of certain Medicare cost-sharing obligations in the context of a clinical trial involving medical devices (the “Proposed Arrangement”).

article thumbnail

Telehealth for Behavioral Healthcare

Verisys

COVID has impacted every aspect of daily life, and these changes have affected people’s mental health, making telehealth services for behavioral health more important than ever. Others may become susceptible to mental health issues, such as depression or anxiety. The use of telemedicine in the U.S.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Executive Health Resources, Inc. , Executive Health Resources, Inc. , 2023) (rejecting any express anti-preemption presumption in Medicare case) ( here ); Baker v. United States Department of Health and Human Services , 58 F.4th In 2023, these include United States ex rel. Polansky v. 3d 239 (Cal.

FDA 105